| Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation D Wrapp, N Wang, KS Corbett, JA Goldsmith, CL Hsieh, O Abiona, ... Science 367 (6483), 1260-1263, 2020 | 10430 | 2020 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1627 | 2020 |
| Site-specific glycan analysis of the SARS-CoV-2 spike Y Watanabe, JD Allen, D Wrapp, JS McLellan, M Crispin Science 369 (6501), 330-333, 2020 | 1611 | 2020 |
| Structure-based design of prefusion-stabilized SARS-CoV-2 spikes CL Hsieh, JA Goldsmith, JM Schaub, AM DiVenere, HC Kuo, ... Science 369 (6510), 1501-1505, 2020 | 1222 | 2020 |
| Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen J Pallesen, N Wang, KS Corbett, D Wrapp, RN Kirchdoerfer, HL Turner, ... Proceedings of the National Academy of Sciences 114 (35), E7348-E7357, 2017 | 1170 | 2017 |
| Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus JS McLellan, M Chen, MG Joyce, M Sastry, GBE Stewart-Jones, Y Yang, ... science 342 (6158), 592-598, 2013 | 1089 | 2013 |
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 JS McLellan, M Pancera, C Carrico, J Gorman, JP Julien, R Khayat, ... Nature 480 (7377), 336-343, 2011 | 1062 | 2011 |
| Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody JS McLellan, M Chen, S Leung, KW Graepel, X Du, Y Yang, T Zhou, ... Science 340 (6136), 1113-1117, 2013 | 919 | 2013 |
| Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein L Casalino, Z Gaieb, JA Goldsmith, CK Hjorth, AC Dommer, AM Harbison, ... ACS central science 6 (10), 1722-1734, 2020 | 914 | 2020 |
| Pre-fusion structure of a human coronavirus spike protein RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ... Nature 531 (7592), 118-121, 2016 | 873 | 2016 |
| Immunogenicity of a DNA vaccine candidate for COVID-19 TRF Smith, A Patel, S Ramos, D Elwood, X Zhu, J Yan, EN Gary, ... Nature communications 11 (1), 2601, 2020 | 714 | 2020 |
| Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies D Wrapp, D De Vlieger, KS Corbett, GM Torres, N Wang, W Van Breedam, ... Cell 181 (5), 1004-1015. e15, 2020 | 686 | 2020 |
| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 575 | 2020 |
| Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis RN Kirchdoerfer, N Wang, J Pallesen, D Wrapp, HL Turner, CA Cottrell, ... Scientific reports 8 (1), 15701, 2018 | 552 | 2018 |
| Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes JS McLellan, Y Yang, BS Graham, PD Kwong Journal of virology 85 (15), 7788-7796, 2011 | 495 | 2011 |
| Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 M Rolland, PT Edlefsen, BB Larsen, S Tovanabutra, E Sanders-Buell, ... Nature 490 (7420), 417-420, 2012 | 494 | 2012 |
| The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates NI Mazur, D Higgins, MC Nunes, JA Melero, AC Langedijk, N Horsley, ... The Lancet Infectious Diseases 18 (10), e295-e311, 2018 | 465 | 2018 |
| The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... Science translational medicine 13 (593), eabf1906, 2021 | 453 | 2021 |
| Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2 HX Liao, M Bonsignori, SM Alam, JS McLellan, GD Tomaras, MA Moody, ... Immunity 38 (1), 176-186, 2013 | 449 | 2013 |
| Structure and function of respiratory syncytial virus surface glycoproteins JS McLellan, WC Ray, ME Peeples Challenges and opportunities for respiratory syncytial virus vaccines, 83-104, 2013 | 431 | 2013 |
